State-backed investors co-lead nine-figure round for China's Matwings
What's the deal? Shanghai-based Matwings TechnologyDealroom has a profile for this one. Try Dealroom → has raised several hundred million yuan in a Series A++ round to advance its automated AI protein design platform. State-backed investment platforms Shanghai Guotou Lead and SDIC Innovation co-led the round, announced in July 2026.
Who else backed it? Existing shareholder Qiming Venture Partners joined alongside regional venture funds. The involvement of two state-linked lead investors signals strong institutional confidence in the startup.
What's the endgame? Matwings builds specialised machine learning infrastructure for biology. Proceeds will fund engineering iteration of its proprietary closed-loop agent, MatwingsVenus, and expand commercial deployment across advanced pharmaceutical materials, the circular economy, and consumer health.
Why now? Capital on the Chinese mainland is increasingly favouring applied "AI for Science" systems that replace multi-year laboratory work with predictive computational workflows. Matwings uses machine learning to bypass iterative wet-lab screening.
The signal: The round reflects a broader shift, turning structural biology platforms from academic modelling tools into self-directed industrial synthesis pipelines. Backing from state investors underscores how much Beijing-aligned capital is prioritising the sector.
Read more: TMTPost
Image credit: Generated with Gemini
